Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.

[1]  J. Bergh,et al.  Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. , 2003, European journal of cancer.

[2]  G. Molenberghs,et al.  Multicollinearity in prognostic factor analyses using the EORTC QLQ‐C30: identification and impact on model selection , 2002, Statistics in medicine.

[3]  M. Piccart,et al.  Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Norman,et al.  Baseline quality of life predicts survival in patients with advanced colorectal cancer. , 2002, European journal of cancer.

[5]  P. Ganz,et al.  Beyond the development of quality-of-life instruments: where do we go from here? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Sprangers.  Quality-of-Life Assessment in Oncology , 2002, Acta oncologica.

[7]  A. Bezjak,et al.  Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[8]  J. Bergh,et al.  Timing of quality of life (QoL) assessments as a source of error in oncological trials. , 2001, Journal of advanced nursing.

[9]  D. Alderson,et al.  The prognostic value of quality of life scores during treatment for oesophageal cancer , 2001, Gut.

[10]  M. Morgan,et al.  Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Jassem,et al.  Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Ali Montazeri,et al.  Quality of life in lung cancer patients: as an important prognostic factor. , 2001, Lung cancer.

[13]  G. Hordijk,et al.  Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. , 2001, European journal of cancer.

[14]  R. Gelber,et al.  Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Klijn,et al.  Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. , 2000, European journal of cancer.

[16]  H. Fukuda,et al.  European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .

[17]  D. Osoba.  What has been learned from measuring health-related quality of life in clinical oncology. , 1999, European journal of cancer.

[18]  P Selby,et al.  Quality of life instruments in oncology. , 1999, European journal of cancer.

[19]  J. Holland,et al.  Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? , 1999, Cancer.

[20]  J. Donovan,et al.  Reporting on quality of life in randomised controlled trials: bibliographic study , 1998, BMJ.

[21]  H. Thaler,et al.  Quality of life and survival , 1998, Cancer.

[22]  S. Kong,et al.  Methodologic Assessments of Quality of Life Measures in Clinical Trials , 1997, The Annals of pharmacotherapy.

[23]  F. WislØff,et al.  Health‐related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma , 1997, British journal of haematology.

[24]  D. Osoba,et al.  Guidelines for reporting results of quality of life assessments in clinical trials , 1996, Quality of Life Research.

[25]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  K R Hess,et al.  Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. , 1995, Statistics in medicine.

[27]  C. Brunelli,et al.  The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. , 1995, Lung cancer.

[28]  Moinpour Cm.  Measuring quality of life: an emerging science. , 1994 .

[29]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[30]  J F Forbes,et al.  Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Schumacher,et al.  Assessment of quality of life in clinical trials. , 1991, Statistics in medicine.

[32]  P. Ganz,et al.  Quality of life assessment. An independent prognostic variable for survival in lung cancer , 1991, Cancer.

[33]  O. Kallioniemi,et al.  Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. , 1990, British Journal of Cancer.

[34]  G. Hortobagyi,et al.  Clinical course of breast cancer patients with liver metastases. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Williams,et al.  Survival patterns in hormone treated advanced breast cancer , 1986, The British journal of surgery.

[36]  G. Hortobagyi,et al.  Prognostic factors in metastatic breast cancer treated with combination chemotherapy. , 1979, Cancer research.

[37]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[38]  M. Friedman.  The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance , 1937 .

[39]  R. Blamey,et al.  Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy , 2005, Breast Cancer Research and Treatment.

[40]  R. Feld.  Endpoints in cancer clinical trials: is there a need for measuring quality of life? , 2004, Supportive Care in Cancer.

[41]  D. Osoba,et al.  Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy , 2004, Quality of Life Research.

[42]  P. Dombernowsky,et al.  Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[44]  C. Glover,et al.  Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[46]  P. Hersey,et al.  Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. , 1993, European journal of cancer.

[47]  M Schumacher,et al.  A bootstrap resampling procedure for model building: application to the Cox regression model. , 1992, Statistics in medicine.

[48]  D. Cox.  Regression Models and Life-Tables , 1972 .